4.6 Article

Lempel-Ziv complexity in schizophrenia: A MEG study

Journal

CLINICAL NEUROPHYSIOLOGY
Volume 122, Issue 11, Pages 2227-2235

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.clinph.2011.04.011

Keywords

Schizophrenia; Lempel-Ziv complexity; Magnetoencephalography; Neurodevelopmental; Neurodegenerative

Funding

  1. FUNDACION MUTUA MADRI-LENA
  2. Lilly S.A. Spain
  3. Serono
  4. Organon
  5. Pfizer
  6. Eli Lilly
  7. Bristol-Myers Squibb
  8. Lundbeck
  9. Servier
  10. Janssen-Cilagg Lundbeck
  11. Boehringer-Ingelheim
  12. Jansen-Organon
  13. Wyeth

Ask authors/readers for more resources

Objective: The neurodevelopmental-neurodegenerative debate is a basic issue in the field of the neuropathological basis of schizophrenia (SCH). Neurophysiological techniques have been scarcely involved in such debate, but nonlinear analysis methods may contribute to it. Methods: Fifteen patients (age range 23-42 years) matching DSM IV-TR criteria for SCH, and 15 sex-and age-matched control subjects (age range 23-42 years) underwent a resting-state magnetoencephalographic evaluation and Lempel-Ziv complexity (LZC) scores were calculated. Results: Regression analyses indicated that LZC values were strongly dependent on age. Complexity scores increased as a function of age in controls, while SCH patients exhibited a progressive reduction of LZC values. A logistic model including LZC scores, age and the interaction of both variables allowed the classification of patients and controls with high sensitivity and specificity. Conclusions: Results demonstrated that SCH patients failed to follow the normal'' process of complexity increase as a function of age. In addition, SCH patients exhibited a significant reduction of complexity scores as a function of age, thus paralleling the pattern observed in neurodegenerative diseases. Significance: Our results support the notion of a progressive defect in SCH, which does not contradict the existence of a basic neurodevelopmental alteration. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available